2022 - 01 - 17

Menarini Diagnostics CoronaMeltVAR Real-Time PCR kit simultaneously detects SARS CoV-2 and identifies the Omicron Variant

2022 - 02 - 02

Conversations with Nobel Prize Winners: The Fondazione Menarini launches their “Dialogs Beyond Borders” series

2022 - 03 - 14

MENARINI DIAGNOSTICS DETECTS ALL COVID VARIANTS

2022 - 05 - 08

Raffaello, maestro di armonia e difensore dei beni culturali protagonista del volume d’arte di Menarini

2022 - 05 - 09

Berlin-Chemie Menarini’s position in Ukraine

2022 - 05 - 20

Menarini Group and Radius Health, Inc. announce publication of elacestrant pivotal Phase 3 EMERALD clinical trial data in the Journal of Clinical Oncology

2022 - 05 - 20

Karyopharm and Menarini Group Receive Positive CHMP Opinion for NEXPOVIO^® (selinexor) for the Treatment of Patients with Refractory Multiple Myeloma

2022 - 05 - 26

Menarini inaugurates new regional headquarters in Dubai, UAE

2022 - 06 - 06

Menarini Group and Radius Health, Inc. present a subgroup analysis from the elacestrant pivotal phase 3 EMERALD clinical trial at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting

2022 - 06 - 07

Premio Internazionale Fair Play Menarini, assegnato il Premio speciale Fiamme Gialle “Studio e sport”

2022 - 06 - 22

Menarini Group and Radius Health Submit New Drug Application to the U.S. FDA for Elacestrant

2022 - 06 - 23

The XXVI Fair Play Menarini International Award opens with a press conference at CONI

2022 - 06 - 28

NewAmsterdam Pharma and the Menarini Group Sign Licensing Deal to Commercialize Obicetrapib in Europe

2022 - 06 - 30

Il Premio Internazionale Fair Play Menarini arriva a Firenze, presentata la XXVI edizione a Palazzo Vecchio

2022 - 07 - 04

Il XXVI Premio Internazionale Fair Play Menarini debutta a Firenze, “I campioni si raccontano” in diretta tv dal Salone dei Cinquecento

2022 - 07 - 06

Premio Internazionale Fair Play Menarini: dopo “I campioni si raccontano” la cena di gala in attesa della cerimonia di premiazione

2022 - 07 - 07

Sport’s finest gather under the stars for the grand finale of the XXVI Fair Play Menarini International Award

2022 - 07 - 21

Karyopharm and Menarini Receive Full Marketing Authorisation from the European Commission for NEXPOVIO^® (selinexor) for the Treatment of Patients with Multiple Myeloma After at Least One Prior Therapy

2022 - 08 - 02

Context Therapeutics and The Menarini Group Announce Clinical Trial Collaboration and Supply Agreement to Evaluate ONA-XR and Elacestrant Combination

2022 - 08 - 04

ATGC Co., Ltd. License Agreement Grants RELIFE S.r.l. Exclusive Rights to Register, Promote, Distribute, and Market the Novel Botulinum Toxin Type A (ATGC-100) in Europe and the United Kingdom.

2022 - 08 - 11

Menarini Group’s Elacestrant Granted Priority Review by the U.S. FDA for Patients with ER+/HER2- Advanced or Metastatic Breast Cancer

2022 - 08 - 19

Menarini Group’s Elacestrant Marketing Authorization Application Accepted for Review by the European Medicines Agency (EMA) for the Treatment of ER+/HER2- Advanced or Metastatic Breast Cancer

2022 - 09 - 08

Nasce ON RADAR il laboratorio di pensieri, idee, dialogo

2022 - 10 - 14

Giorgione: Maestro di mistero, tra Rinascimento e modernità. Domani a Venezia la presentazione del volume d'arte di Menarini dedicato all'artista

2022 - 11 - 01

Karyopharm and Menarini Group Announce Orphan Medicinal Product Designation from the European Commission for Selinexor for the Treatment of Myelofibrosis

2022 - 11 - 02

QuantuMDx and Menarini Announce an Exclusive Distribution Agreement for the Q-POC™ Platform

2022 - 11 - 24

Le Volpi Rosse Menarini continuano la loro avventura in Serie A

2022 - 11 - 29

Lost childhood: a 'tight-knit' network to combat abuse and distress

2022 - 11 - 30

Menarini Group Presents Updated Results from Pivotal Phase 3 EMERALD Trial at the 2022 San Antonio Breast Cancer Symposium (SABCS)

2022 - 12 - 14

Circulating Tumor Cell detection by Menarini Group’s CELLSEARCH^® System leading to genomic profiling of myeloma cells shows potential for non-invasive management of Multiple Myeloma patients at early

2022 - 12 - 19

Carrick Therapeutics and The Menarini Group Announce Clinical Trial Collaboration to Evaluate Samuraciclib and Elacestrant Combination